104 related articles for article (PubMed ID: 19489217)
1. [Importance of routine pathological assessment of breast cancer].
Zheng J
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):5-7. PubMed ID: 19489217
[No Abstract] [Full Text] [Related]
2. [Histological features of breast cancer as predictive factors for chemotherapy].
Horii R; Akiyama F
Nihon Rinsho; 2007 Jun; 65 Suppl 6():160-4. PubMed ID: 17679197
[No Abstract] [Full Text] [Related]
3. Hormone receptor-positive invasive lobular and ductal carcinoma of the breast have comparable hormone receptor expression levels both if detected by screening and clinically.
Ravaioli A; Falcini F; Bucchi L
Breast Cancer Res Treat; 2018 Feb; 167(3):817-818. PubMed ID: 29027616
[No Abstract] [Full Text] [Related]
4. B7-h4 is highly expressed in ductal and lobular breast cancer.
Tringler B; Zhuo S; Pilkington G; Torkko KC; Singh M; Lucia MS; Heinz DE; Papkoff J; Shroyer KR
Clin Cancer Res; 2005 Mar; 11(5):1842-8. PubMed ID: 15756008
[TBL] [Abstract][Full Text] [Related]
5. Molecular and morphologic distinctions between infiltrating ductal and lobular carcinoma of the breast.
Yoder BJ; Wilkinson EJ; Massoll NA
Breast J; 2007; 13(2):172-9. PubMed ID: 17319859
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial.
Müller V; Gade S; Steinbach B; Loibl S; von Minckwitz G; Untch M; Schwedler K; Lübbe K; Schem C; Fasching PA; Mau C; Pantel K; Schwarzenbach H
Breast Cancer Res Treat; 2014 Aug; 147(1):61-8. PubMed ID: 25086636
[TBL] [Abstract][Full Text] [Related]
7. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
8. TYMS, MTHFR, p53 and MDR1 gene polymorphisms in breast cancer patients treated with adjuvant therapy.
Henríquez-Hernández LA; Pérez LF; Hernández AG; de León AC; Díaz-Chico B; Rosales AM
Cancer Epidemiol; 2010 Aug; 34(4):490-3. PubMed ID: 20371218
[TBL] [Abstract][Full Text] [Related]
9. TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab.
Glück S; Ross JS; Royce M; McKenna EF; Perou CM; Avisar E; Wu L
Breast Cancer Res Treat; 2012 Apr; 132(3):781-91. PubMed ID: 21373875
[TBL] [Abstract][Full Text] [Related]
10. Pathological controversies in breast cancer: classification of ductal carcinoma in situ, sentinel lymph nodes and low volume metastatic disease and reporting of neoadjuvant chemotherapy specimens.
Provenzano E; Brown JP; Pinder SE
Clin Oncol (R Coll Radiol); 2013 Feb; 25(2):80-92. PubMed ID: 23199579
[TBL] [Abstract][Full Text] [Related]
11. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.
Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z
Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor response.
Rody A; Karn T; Gätje R; Ahr A; Solbach C; Kourtis K; Munnes M; Loibl S; Kissler S; Ruckhäberle E; Holtrich U; von Minckwitz G; Kaufmann M
Breast; 2007 Feb; 16(1):86-93. PubMed ID: 17010609
[TBL] [Abstract][Full Text] [Related]
13. [A case of combined noninvasive ductal and lobular carcinoma].
Nagashima S; Sakurai K; Suzuki S; Hara Y; Waga E; Iizuka M; Fuchinoue T; Hirano T; Enomoto K; Tani M; Masuda S; Amano S; Koshinaga T
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2033-5. PubMed ID: 23267967
[TBL] [Abstract][Full Text] [Related]
14. [Value of diffusion weighted imaging (DWI) in evaluating early response to neoadjuvant chemotherapy in locally advanced breast cancer].
Wang XH; Peng WJ; Tan HN; Xin C; Gu YJ; Tang F; Mao J
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):377-81. PubMed ID: 20723438
[TBL] [Abstract][Full Text] [Related]
15. [A case of multicentric breast cancer in which an effect of neoadjuvant chemotherapy had a disparity].
Kashiwagi S; Kawajiri H; Noda S; Takashima T; Onoda N; Nakata B; Kato Y; Ishikawa T; Hirakawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2775-7. PubMed ID: 21224709
[TBL] [Abstract][Full Text] [Related]
16. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
17. Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.
Tanioka M; Sasaki M; Shimomura A; Fujishima M; Doi M; Matsuura K; Sakuma T; Yoshimura K; Saeki T; Ohara M; Tsurutani J; Watatani M; Takano T; Kawabata H; Mukai H; Naito Y; Hirokaga K; Takao S; Minami H
Breast; 2014 Aug; 23(4):466-72. PubMed ID: 24742606
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CERS2 in invasive breast cancer tissues and its clinical significance].
Wang YY; Gao LY; Zhao YH; Li JY; Luo Q; Fan SH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):267-8. PubMed ID: 23928536
[No Abstract] [Full Text] [Related]
19. Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.
Wenzel C; Bartsch R; Hussian D; Pluschnig U; Altorjai G; Zielinski CC; Lang A; Haid A; Jakesz R; Gnant M; Steger GG
Breast Cancer Res Treat; 2007 Jul; 104(1):109-14. PubMed ID: 17061042
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of breast cancer].
Tang P; Wei B; Yang WJ; Liu YS; Bu H
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):73-6. PubMed ID: 21426799
[No Abstract] [Full Text] [Related]
[Next] [New Search]
